JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis
- 31 August 2003
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 125 (2), 556-571
- https://doi.org/10.1016/s0016-5085(03)00904-1
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare (H12-Cancer-020)
- Cancer Research UK
This publication has 46 references indexed in Scilit:
- Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasmHepatology, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisThe New England Journal of Medicine, 2000
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Choline Deficiency Causes Increased Localization of Transforming Growth Factor-β1 Signaling Proteins and Apoptosis in the Rat LiverPathobiology, 1997
- Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human MacrophagesBiochemical and Biophysical Research Communications, 1995
- Increased Cell Proliferation of Azoxymethane-induced Aberrant Crypt Foci of Rat ColonJapanese Journal of Cancer Research, 1994
- Prevention by acetylsailcylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in ratsCarcinogenesis: Integrative Cancer Research, 1994
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesThe New England Journal of Medicine, 1993
- Nonsteroidal Anti-inflammatory Drug Toxicity: Increased Risk in the ElderlyScandinavian Journal of Rheumatology, 1991
- Single GST-P positive liver cells — putative initiated. hepatocytesCarcinogenesis: Integrative Cancer Research, 1987